Gout
-
healthGlobal Gout Burden Driven by Kidney Dysfunction
Kidney dysfunction increased global gout disability over three decades, with older men most affected. Targeted screening and management are critical.
-
healthGout Medication Linked to Reduced Heart Attack and Stroke Risk
New research suggests common gout medications like allopurinol may significantly lower the risk of heart attack and stroke in patients.
-
healthGout Biomarkers Uncover New Metabolic and Genetic Targets
New multi-omics research identifies key metabolic biomarkers and tissue-specific genes linked to gout, revealing potential therapeutic targets beyond uric acid.
-
healthOzempic-Like Drugs Linked to Increased Bone and Joint Condition Risk
New study suggests GLP-1 medications like Ozempic may slightly elevate risks of osteoporosis, gout, and osteomalacia, prompting calls for bone health monitoring.
-
healthGLP-1 Drugs Linked to Increased Fracture, Osteoporosis, and Gout Risk in New Studies
New research suggests GLP-1 medications like Ozempic and Wegovy may elevate fracture risk and exacerbate osteoporosis and gout, particularly in older adults.